• Promethera closes Series D funding round to support expansion pharmaceutical-technology
    December 17, 2019
    Cell-based drugs developer Promethera Biosciences has closed a Series D financing round to support its expansion in Asian markets, along with the development of liver disease programmes.
  • Promethera looks to Asia with €10m investment pharmaphorum
    January 03, 2019
    Belgium-based liver disease specialists Promethera Biosciences have received a leg-up for the Asian market in the form of a €10 million investment from Japanese business conglomerate ITOCHU Corporation.
PharmaSources Customer Service